Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer
Journal of Cachexia, Sarcopenia and Muscle · 2026
DOI: 10.1002/jcsm.70183 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Lindsey J Anderson und 9 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Weight Loss, Metabolomics, Neoplasms, Cachexia. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Background
Treatments for cancer cachexia, defined as involuntary weight and muscle mass loss leading to significant functional impairment, remain unavailable partly due to insufficient improvement of clinically meaningful outcomes in current trials. By reflecting downstream effects of cellular function, metabolomics may identify mechanisms contributing to poor functional performance. Previous metabolomic studies in cancer cachexia have identified alterations in amino acid metabolism with weight loss or low muscularity; none have examined perturbations with poor physical function. We hypothesized that distinct metabolic signals in plasma and muscle are associated with weight loss, low muscle mass, and impaired function in cancer cachexia.
Methods
We enrolled patients planning elective laparotomy for gastrointestinal or genitourinary cancer. Handgrip strength (HGS), stair climb power (SCP), and fasting plasma were collected within 2 weeks prior to surgery; rectus abdominis samples were obtained during surgery. Metabolomic perturbations associated with physical function (HGS, SCP), muscularity (lumbar cross‐sectional area ‘CSA’ from opportunistic CT), or weight loss (> 5% over previous 6 months) were examined in plasma and muscle. The Mann–Whitney U‐test compared metabolite abundance between weight‐losing and weight‐stable patients, while Spearman's correlation tested associations of abundance with CSA, HGS, or SCP. The ‘Globaltest’ method assessed pathway alterations with weight loss, CSA, HGS, or SCP; the Benjamini‐Hochberg adjustment was used to control for false discovery.
Results
Patients ( N = 72) were male, median age 65 [interquartile range: 59–70], with 57% genitourinary cancer. Plasma and skeletal muscle metabolomic data were collected ( N = 64 and N = 68, respectively). Weight loss was associated with significantly altered microbial, amino acid/derivative, fatty acid/lipid, and caffeine‐related metabolism pathways in plasma (adjusted p < 0.1). Lower CSA was associated with significantly altered fatty acid/lipid, galactose, glycerophospholipid, and histidine metabolism and bile secretion pathways in skeletal muscle (adjusted p < 0.1). Worse HGS was nominally associated with altered plasma branched chain amino acid biosynthesis and altered skeletal muscle glutathione metabolism (unadjusted p ≤ 0.05), while worse SCP was nominally associated with altered skeletal muscle amino sugar/nucleotide sugar metabolism and phenylalanine, tyrosine, and tryptophan biosynthesis (unadjusted p ≤ 0.05).
Conclusions
Significant metabolomic alterations in plasma and skeletal muscle characterized cancer‐related weight loss and reduced CSA, respectively. Nominal, function‐specific alterations were detected with worse HGS and SCP, which were distinct from those associated with weight loss or low CSA. Future larger studies may further characterize metabolomic profiles related to various functional outcomes and guide development of therapeutic targets to improve functional performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatric Research, Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
- Department of Medicine, Division of Gerontology and Geriatric Medicine, University of Washington, Seattle, Washington, USA.
- Department of Statistics and Probability, Michigan State University, East Lansing, Michigan, USA.
- Department of Surgery, University of Washington, Seattle, Washington, USA.
- Department of Surgery, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
- Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
ORCID-Profile: Lindsey J Anderson, Jose M Garcia
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- BLRD VA
- NIA NIH HHS
Zitieren
APA
Anderson, L. J., Xia, L., Kerr, H., Cabrera, M., Chu, F., Rose, J., Wu, P. C., Dash, A., Gharib, S. A., & Garcia, J. M. (2026). Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70183
Vancouver
Anderson LJ, Xia L, Kerr H, Cabrera M, Chu F, Rose J, et al. Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70183
BibTeX
@article{Anderson2026,
author = {Anderson, Lindsey J and Xia, Lu and Kerr, Haiming and Cabrera, Marin and Chu, Fabien and Rose, Jaqueline and Wu, Peter C and Dash, Atreya and Gharib, Sina A and Garcia, Jose M},
title = {Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
doi = {10.1002/jcsm.70183}
}
EUVIMED